Benefit of Adjuvant Chemoradiotherapy for Gastric Adenocarcinoma: A SEER Population Analysis

BACKGROUND: Despite results of the Intergroup 0116 (INT-0116) study showing an overall survival benefit of adjuvant chemoradiotherapy in gastric adenocarcinoma, its use in the United States remains controversial. The Surveillance Epidemiology of End Results (SEER) database was used to compare cause-...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Seyedin, Steven, Wang, Pin-Chieh, Zhang, Quan, Lee, Percy
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Society of Gastrointestinal Oncology 2014
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171970/
https://ncbi.nlm.nih.gov/pubmed/25276261
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak